SITC 2025

The Society for Immunotherapy of Cancer (SITC) will host its 40th Anniversary Annual Meeting and Pre-Conference Programs this year, bringing together international leaders from academia, regulatory and government agencies and industry to commemorate four decades of advancements in cancer immunotherapy.

The meeting aims to improve outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy, attracting a diverse audience of basic and clinical investigators, clinicians, translational researchers, graduate students, post-doctoral fellows, allied health professionals, pharmacists and payers.